New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
1

'Promising' Cell-Therapy Trials for Clinical CAD Halted Early

RENEW's plug was pulled for financial reasons, not safety or efficacy issues, say researchers, or it might have led to a groundbreaking US approval; hopes for it and the ATHENA trials had been high.  
medscape.com
about 4 years ago
Preview
0
2

Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years

A postmortem report showing transplanted dopaminergic cells survived for almost a quarter of a century provides hope for future stem cell therapy, researchers say.  
medscape.com
about 4 years ago
Preview
0
0

No Brain Tumor, Cell Phone Link, Study Says; Expert Not Sure

According to a large study, there is no link between cell-phone use and a higher risk for brain tumor, but one expert has doubts about the finding.  
medscape.com
about 4 years ago
Preview
0
0

Medicine's Future, From a Leader in Genome Editing and Stem Cells

Eric Topol speaks with Chad Cowan, of the Harvard Stem Cell Institute, about how regenerative medicine may soon cure diseases like type 1 diabetes and Parkinson disease.  
medscape.com
about 4 years ago
Preview
0
0

Stem Cell Therapy for Spinal Cord Injury: A Status Report

International clinics are using stem cells to treat spinal cord injury, with some encouraging results. But with the science in its infancy and therapy risky, are they jeopardizing desperate patients?  
medscape.com
over 4 years ago
Preview
0
7

Success With Stem Cell Transplant in Myasthenia Gravis

Seven patients with severe myasthenia gravis who received autologous hematopoietic stem cell transplants have experienced long-term remission.  
medscape.com
over 4 years ago
Preview
0
1

Immunotherapy in the Prevention of Alzheimer Disease

Dr Jacobs reviews the results of a recent study evaluating passive immunotherapy with encapsulated cell implants to target misfolded proteins in the prevention of Alzheimer disease.  
medscape.com
over 4 years ago
Preview
0
0

Device Captures Circulating Tumor Cells, Keeps Them Alive for Testing |

Fluorescence probes in two breast cancer cells give information about which genes are present. The green dots show that both cells have multiple copies of  
medgadget.com
over 4 years ago
Preview
0
6

EMA Panel Backs Daclizumab (Zinbryta) for Multiple Sclerosis

Daclizumab, a once-monthly injection, offers a targeted mechanism of action that is not expected to cause broad and prolonged immune cell depletion.  
medscape.com
over 4 years ago
Preview
0
0

Should We Bring Back the Whole-Cell Pertussis Vaccine?

Priming with whole-cell and then finishing with acellular pertussis vaccine would better protect children from pertussis, says Paul Offit.  
medscape.com
over 4 years ago
Preview
0
8

MRI, Macrophages Help Predict Prognosis in Glioblastoma

For patients with glioblastoma multiforme, combining MRI tumor features with cancer-associated macrophage status could allow clinicians to more accurately predict outcomes.  
medscape.com
over 4 years ago
Preview
0
4

'Remarkable' Responses in Rare Merkel-Cell Skin Cancer

The first-ever positive clinical trial in the rare Merkel-cell carcinoma shows the highest responses to immunotherapy yet seen, in 56% of patients.  
medscape.com
over 4 years ago
Preview
0
0

Endovascular treatment for stroke

Shortly after a clot occludes a cerebral artery, cells in the infarct core—the most severely ischaemic area—start dying. The tissue surrounding the ischaemic core, the penumbra, is hypoperfused and at risk of progressing to infarction over minutes to hours, depending on the degree of ischaemia. The goal of treatment for acute stroke is to restore blood flow to these potentially salvageable areas as soon as possible. Thrombolysis is traditionally used, but in this issue Rodrigues and colleagues (doi:10.1136/bmj.i1754) summarise the evidence supporting mechanical thrombectomy.1  
feeds.bmj.com
over 4 years ago
Www.bmj
0
0

Endovascular treatment for stroke

Shortly after a clot occludes a cerebral artery, cells in the infarct core—the most severely ischaemic area—start dying. The tissue surrounding the ischaemic core, the penumbra, is hypoperfused and at risk of progressing to infarction over minutes to hours, depending on the degree of ischaemia. The goal of treatment for acute stroke is to restore blood flow to these potentially salvageable areas as soon as possible. Thrombolysis is traditionally used, but in this issue Rodrigues and colleagues (doi:10.1136/bmj.i1754) summarise the evidence supporting mechanical thrombectomy.1  
feeds.bmj.com
over 4 years ago